Literature DB >> 11083037

Measuring improved patient choice.

M Holmes-Rovner1, D R Rovner.   

Abstract

Patient decision support (PDS) tools or decision aids have been developed as adjuncts to the clinical encounter. Their aim is to support evidence-based patient choice. Clinical trials of PDS tools have used an array of outcome measures to determine efficacy, including knowledge, satisfaction, health status and consistency between patient choice and values. This paper proposes that the correlation between 'subjective expected utility' (SEU) and decision may be the best primary endpoint for trials. SEU is a measure usually used in behavioural decision theory. The paper first describes how decision support tools may use decision analysis to structure the presentation of evidence and guide patient decision-making. Uses of expected utility (EU) are suggested for evaluating PDS tools when improving population health status is the objective. SEU is the theoretically better measure when internal consistency of patient choices is the objective.

Entities:  

Mesh:

Year:  2000        PMID: 11083037     DOI: 10.1046/j.1365-2753.2000.00258.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  6 in total

1.  Likely consequences of increased patient choice.

Authors:  Margaret Holmes-Rovner
Journal:  Health Expect       Date:  2005-03       Impact factor: 3.377

2.  Impact of a Multifaceted Intervention on Promoting Adherence to Screening Colonoscopy Among Persons in HIV Primary Care: A Pilot Study.

Authors:  Pansy Ferron; Shihab S Asfour; Lisa R Metsch; Michael H Antoni; Allan E Rodriguez; Robert Duncan; Sheila M Findlay
Journal:  Clin Transl Sci       Date:  2015-05-21       Impact factor: 4.689

3.  Clinician-patient agreement about the work disability problem of patients having persistent pain: why it matters.

Authors:  Marie-France Coutu; Raymond Baril; Marie-José Durand; Daniel Côté; Geneviève Cadieux
Journal:  J Occup Rehabil       Date:  2013-03

Review 4.  On what basis should the effectiveness of decision aids be judged?

Authors:  Andrew D M Kennedy
Journal:  Health Expect       Date:  2003-09       Impact factor: 3.377

5.  How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

Authors:  A M Sawka; S Straus; A Gafni; J D Brierley; R W Tsang; L Rotstein; S Ezzat; L Thabane; G Rodin; S Meiyappan; D David; D P Goldstein
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

6.  The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.

Authors:  Anna M Sawka; David P Goldstein; James D Brierley; Richard W Tsang; Lorne Rotstein; Shereen Ezzat; Sharon Straus; Susan R George; Susan Abbey; Gary Rodin; Mary Ann O'Brien; Amiram Gafni; Lehana Thabane; Jeannette Goguen; Asima Naeem; Lilian Magalhaes
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.